Australia’s pharmaceutical benefits scheme is not up for negotiation, says the federal government in the face of ramped-up US ...

President Trump is readying plans for industry-specific tariffs to kick in alongside his country-by-country duties in two ...

President Trump will soon announce new "Section 232" tariffs on pharmaceutical imports to bolster national security. This ...

A 25% U.S. tariff on pharmaceutical imports would increase U.S. drug costs by nearly $51 billion annually, boosting U.S. prices by as much as 12.9% if passed on, a report commissioned by the ...

Diederik Stadig, a healthcare analyst at ING, estimated that tariffs on all pharmaceutical imports to the U.S. would increase the price for low-cost, generic drugs by up to $0.12 per pill, or an ...

If the Trump administration imposes a 25% tariff on drug imports, it could increase prices by nearly 13% and cost the U.S. some $51 billion annually, according to Reuters, which accessed a ...

The imposition of tariffs on pharmaceutical imports—either directly or indirectly through raw materials and active pharmaceutical ingredients (APIs)—can profoundly impact drug prices ...